Molecular Therapy — Nucleic Acids · 2013 · 71 citations · 39 references
Life SciencesInfectious DiseasesPharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceHost-pathogen InteractionsAntibacterial AgentsAntibacterial ResistanceAntibacterial TherapyAntibiotic ResistanceAntibiotic Resistance MechanismsAntimicrobial PeptidesAntibacterial PeptidesAntimicrobial Growth InhibitionPenicillin ResistancePeptide ConjugatesPeptide-drug ConjugatesResistance Mechanisms In StreptococciRibosomal Rna FunctionTherapeutic Growth Inhibition
While Streptococcus pyogenes is consistently susceptible toward penicillin, therapeutic failure of penicillin treatment has been reported repeatedly and a considerable number of patients exhibit allergic reactions to this substance. At the same time, streptococcal resistance to alternative antibiotics, e.g., macrolides, has increased. Taken together, these facts demand the development of novel therapeutic strategies. In this study, S. pyogenes growth was inhibited by application of peptide-conjugated antisense-peptide nucleic acids (PNAs) specific for the essential gyrase A gene (gyrA). Thereby, HIV-1 Tat peptide-coupled PNAs were more efficient inhibitors of streptococcal growth as compared with (KFF)3K-coupled PNAs. Peptide-anti-gyrA PNAs decreased the abundance of gyrA transcripts in S. pyogenes. Growth inhibition by antisense interference was enhanced by combination of peptide-coupled PNAs with protein-level inhibitors. Antimicrobial synergy could be detected with levofloxacin and novobiocin, targeting the gyrase enzyme, and with spectinomycin, impeding ribosomal function. The prospective application of carrier peptide-coupled antisense PNAs in S. pyogenes covers the use as an antimicrobial agent and the employment as a knock-down strategy for the investigation of virulence factor function. While Streptococcus pyogenes is consistently susceptible toward penicillin, therapeutic failure of penicillin treatment has been reported repeatedly and a considerable number of patients exhibit allergic reactions to this substance. At the same time, streptococcal resistance to alternative antibiotics, e.g., macrolides, has increased. Taken together, these facts demand the development of novel therapeutic strategies. In this study, S. pyogenes growth was inhibited by application of peptide-conjugated antisense-peptide nucleic acids (PNAs) specific for the essential gyrase A gene (gyrA). Thereby, HIV-1 Tat peptide-coupled PNAs were more efficient inhibitors of streptococcal growth as compared with (KFF)3K-coupled PNAs. Peptide-anti-gyrA PNAs decreased the abundance of gyrA transcripts in S. pyogenes. Growth inhibition by antisense interference was enhanced by combination of peptide-coupled PNAs with protein-level inhibitors. Antimicrobial synergy could be detected with levofloxacin and novobiocin, targeting the gyrase enzyme, and with spectinomycin, impeding ribosomal function. The prospective application of carrier peptide-coupled antisense PNAs in S. pyogenes covers the use as an antimicrobial agent and the employment as a knock-down strategy for the investigation of virulence factor function. IntroductionStreptococcus pyogenes (group A streptococci (GAS)) is an exclusively human pathogen, which causes a wide spectrum of infectious diseases ranging from mild superficial infections of the skin and the mucosal membranes to invasive diseases like necrotizing fasciitis (flesh-eating disease) or streptococcal toxic shock syndrome. Typically, superficial infections are associated with spontaneous recovery. However, if mild infections remain untreated, severe invasive infections or autoimmune sequelae can develop as a consequence.1Carapetis JR Steer AC Mulholland EK Weber M The global burden of group A streptococcal diseases.Lancet Infect Dis. 2005; 5: 685-694Abstract Full Text Full Text PDF PubMed Scopus (1903) Google Scholar,2Cunningham MW Pathogenesis of group A streptococcal infections and their sequelae.Adv Exp Med Biol. 2008; 609: 29-42Crossref PubMed Scopus (133) Google Scholar Therefore, antibiotic therapy is strongly indicated upon streptococcal infections. Currently, penicillin is the standard treatment of streptococcal pharyngitis. Reasons are the continuing susceptibility of GAS toward penicillin, its efficiency, safety, and the comparably low costs of penicillin treatment.3Bisno AL Gerber MA Gwaltney Jr, JM Kaplan EL Schwartz RH Infectious Diseases Society of America Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America.Clin Infect Dis. 2002; 35: 113-125Crossref PubMed Scopus (604) Google Scholar,4Dajani A Taubert K Ferrieri P Peter G Shulman S Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association.Pediatrics. 1995; 96 (4 Pt 1): 758-764PubMed Google Scholar,5van Driel ML De Sutter AI Keber N Habraken H Christiaens T Different antibiotic treatments for group A streptococcal pharyngitis.Cochrane Database Syst Rev. 2010; : CD004406PubMed Google Scholar However, penicillin-related treatment failure has been reported repeatedly in cases of streptococcal pharyngitis.6Kuhn SM Preiksaitis J Tyrrel GJ Jadavji T Church D Davies HD Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis.Can J Infect Dis. 2001; 12: 33-39Crossref PubMed Scopus (20) Google Scholar,7Macris MH Hartman N Murray B Klein RF Roberts RB Kaplan EL et al.Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades.Pediatr Infect Dis J. 1998; 17: 377-381Crossref PubMed Scopus (81) Google Scholar Factors that have been discussed to be responsible for this phenomenon include the coexistence of β-lactamase–producing bacteria,8Brook I Gober AE Failure to eradicate streptococci and beta-lactamase producing bacteria.Acta Paediatr. 2008; 97: 193-195Crossref PubMed Scopus (11) Google Scholar biofilm formation by GAS,9Baldassarri L Creti R Recchia S Imperi M Facinelli B Giovanetti E et al.Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation.J Clin Microbiol. 2006; 44: 2721-2727Crossref PubMed Scopus (115) Google Scholar and internalization of GAS into epithelial host cells.10Ogawa T Terao Y Okuni H Ninomiya K Sakata H Ikebe K et al.Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitis.Microb Pathog. 2011; 51: 58-68Crossref PubMed Scopus (61) Google Scholar,11Sela S Neeman R Keller N Barzilai A Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalised by cultured epithelial cells.J Med Microbiol. 2000; 49: 499-502Crossref PubMed Scopus (42) Google Scholar,12Podbielski A Kreikemeyer B Persistence of group A streptococci in eukaryotic cells–a safe place?.Lancet. 2001; 358: 3-4Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar Another problem poses the rising occurrence of macrolide resistance in GAS,13Michos AG Bakoula CG Braoudaki M Koutouzi FI Roma A et resistance in Streptococcus resistance and Infect Dis. Full Text Full Text PDF PubMed Scopus Google J et resistance Streptococcus pyogenes in 2008; PubMed Scopus Google Scholar which the use of to patients with penicillin Shulman treatment failure in streptococcal pharyngitis in acute rheumatic PubMed Scopus Google Scholar the development of novel therapeutic an the therapeutic antisense of antisense interference is the specific on Another is the of resistance toward antisense nucleic acids (PNAs) have been as antimicrobial in the in a of PNAs between and nucleic which are of are in PNAs. However, the nucleic M to nucleic Biol. Google Scholar PNAs a in as as in and their to their in or is to be of PNAs. PNAs to be in human and M et of nucleic acids in human and PubMed Scopus Google is by the in L R in are by the 2000; PubMed Scopus (81) Google Scholar are or that are to eukaryotic cells and can be for the of into B of and by and Rev. 2005; PubMed Scopus Google M M of that with antibiotics PubMed Google Scholar of PNAs into could be by to the M L and of antisense nucleic into 2002; PubMed Scopus Google A antisense nucleic PubMed Scopus Google M K A H growth inhibition by nucleic to the of PubMed Scopus Google P G of gene and growth by antisense nucleic acids in a 51: PubMed Scopus Google Scholar The of essential has been by antisense interference to inhibition of the gene for an factor the gene for the gyrase A the gene for the carrier and the for an P G of gene and growth by antisense nucleic acids in a 51: PubMed Scopus Google H Y H J et inhibition of gene and growth in by of nucleic acids to PubMed Scopus Google A R S M M et in and a Full Text Full Text PDF PubMed Scopus Google Scholar In a has been inhibited by targeting with PNAs specific for the or the M K A H growth inhibition by nucleic to the of PubMed Scopus Google H P A of and growth by nucleic acids to of PubMed Scopus Google a number of PNAs have been in In the antisense was in in and a was to growth M K A H growth inhibition by nucleic to the of PubMed Scopus Google N L of gene and growth antisense nucleic Full Text Full Text PDF PubMed Scopus Google growth of GAS which is a to be responsible for skin and by antisense targeting of the essential gene gene the A of the which is in and is for Growth was PNAs specific for which were to or to PNAs inhibited the growth of GAS more (KFF)3K-coupled a antimicrobial synergy between and growth by carrier peptide-coupled PNAs were to the of gyrA and the of the gene PNAs with and to the which been used to in a of In a of (KFF)3K-coupled PNAs to the is as a the gyrA were PNAs the growth (KFF)3K-coupled PNAs to gyrA and with GAS growth (KFF)3K-coupled PNAs to the of the gyrA to to a of GAS growth nucleic acids (PNAs) and to to to to to in a of (KFF)3K-coupled nucleic acids (PNAs) on GAS growth inhibition of GAS by growth inhibition of GAS by At toxic of the were of the growth inhibition of and the of the growth inhibition of and the for of the PNAs were which the same with PNAs a with that growth by treatment with was specific growth inhibition was by of a of At toxic of the were of the in the of growth is that growth inhibition upon application of of peptide-coupled PNAs is in by toxic of the The of PNAs was At this inhibition is by a combination of a of the antisense and an toxic of the the were in the of The upon treatment with was in the as as in the growth of GAS growth inhibition upon of growth between the abundance of gyrA transcripts in GAS antisense of to the gyrA was by of the gyrA The of the of PNAs on the of gyrA was by by abundance of the gene was used for The gyrA in GAS as treatment with the of gyrA was to of the detected in the of the gyrA detected by of nucleic treatment on the abundance of gyrA was from and The the gyrA compared to the HIV-1 Tat the antimicrobial of more the GAS and growth inhibition were PNAs a were of the to growth inhibition of GAS The of between to the and the HIV-1 Tat by and in the HD AE J P N et the with a formation of J. 97: Full Text Full Text PDF PubMed Scopus Google Scholar In to Tat has been used for into the Tat could be as a for the of into GAS was to gyrA antisense The of on growth of GAS was compared with the growth inhibition by growth in the of was in the of of of to a of the of to growth inhibition of GAS a of Tat to GAS growth inhibition to a of Tat In with PNAs to the a more efficient growth inhibition of GAS of nucleic acids (PNAs) on GAS growth inhibition of GAS by growth inhibition of GAS by of the growth inhibition of and the synergy between peptide-coupled PNAs and gyrase is a of antibiotics and the that treatment is growth to the application of peptide-coupled PNAs with antibiotics to antibiotics were compared with the antibiotics targeting to A used for the of antimicrobial synergy between inhibitors is the G R Antimicrobial in Scholar this the for is of the of agent is with of the growth is for the of the of the the are of to of combination therapy by 1998; PubMed Google Scholar have been to of of of synergy Infect Dis. 2002; 44: Full Text Full Text PDF PubMed Scopus (115) Google Scholar a which be for antimicrobial is a for synergy this as the for the of was by toxic of the carrier these the was for combination of PNAs with antibiotics in GAS be to the of for antimicrobial was N R A in D The of antimicrobial Infect Dis. PubMed Scopus Google of for antimicrobial and antimicrobial Infect Dis. PubMed Scopus Google for antibiotics with the same as inhibitors of gyrase A and gyrase B were were compared with spectinomycin, which to the ribosomal and a from In the for the of PNAs with levofloxacin are as growth of GAS in the of levofloxacin could be detected At a of a growth was was for combination GAS was in the of levofloxacin and of PNAs to the an inhibition of growth could be in with levofloxacin of the growth In in the of or application of a combination of the as a of of the the combination of levofloxacin with synergy was the in this the of levofloxacin these The for and are in and treatment with synergy with was detected of in combination with to synergy was upon of and of levofloxacin with nucleic growth inhibition of GAS by Growth of GAS in the of levofloxacin and of nucleic Growth of GAS in the of levofloxacin and of of the growth nucleic or or in a of with antibiotics to combination of with levofloxacin a was and Treatment with to synergy with of in combination with to from to with the antibiotics and of the growth nucleic or or or or or or or or or or or or or or or or or or in a and synergy with antibiotics in this The was of the by the antimicrobial substance. of peptide-coupled PNAs with antibiotics a growth inhibition application of the of is more to development of antimicrobial antisense PNAs are due to their specific are for their to as as to and their e.g., the of The of antisense PNAs has been in are the of PNAs in to antisense targeting of a gene for an essential in GAS an to its the gyrase a of antibiotics, and and gyrA has been used for in P G of gene and growth by antisense nucleic acids in a 51: PubMed Scopus Google N L of gene and growth antisense nucleic Full Text Full Text PDF PubMed Scopus Google growth in GAS the application of PNAs. However, of PNAs with was for antimicrobial of the is in with the by the has repeatedly been as a factor in antimicrobial this a of has been in the The M S of to PubMed Scopus (133) Google Scholar has been used for of its Another is the of which are to the of M M of that with antibiotics PubMed Google Scholar is the which has been used as a to into M L and of antisense nucleic into 2002; PubMed Scopus Google L R antisense of 2001; PubMed Scopus Google Scholar has been to in and in e.g., S. A antisense nucleic PubMed Scopus Google M K A H growth inhibition by nucleic to the of PubMed Scopus Google P G of gene and growth by antisense nucleic acids in a 51: PubMed Scopus Google N L of gene and growth antisense nucleic Full Text Full Text PDF PubMed Scopus Google Scholar which to be in GAS While of PNAs could be GAS growth was inhibited in the of of (KFF)3K-coupled The for a growth in GAS was with reported from In S. a growth N L of gene and growth antisense nucleic Full Text Full Text PDF PubMed Scopus Google Scholar in were for a P G of gene and growth by antisense nucleic acids in a 51: PubMed Scopus Google Scholar Growth inhibition by (KFF)3K-coupled antisense PNAs specific for for the factor a of in S. and in H Y H J et inhibition of gene and growth in by of nucleic acids to PubMed Scopus Google H G Y Y et as a therapeutic strategy by antisense nucleic PubMed Scopus Google of antisense has been in the inhibition of gene by L inhibition of gene in by to 1998; PubMed Scopus Google Scholar the is The was to be the efficient to inhibition of gene in and of was to be a R L The is to antisense inhibition in PubMed Scopus Google Scholar the of the has been upon of P G of gene and growth by antisense nucleic acids in a 51: PubMed Scopus Google H Y H J et inhibition of gene and growth in by of nucleic acids to PubMed Scopus Google Scholar In GAS a of gyrA abundance to could be detected upon treatment with PNAs have been in application of a of abundance to of the A R S M M et in and a Full Text Full Text PDF PubMed Scopus Google Scholar ribosomal during as and A in the of on 2005; PubMed Scopus Google Scholar a gyrA due to be responsible for a of the gyrA in GAS for the of growth inhibition in GAS was reported from inhibition The in between and on the M A H nucleic acids (PNAs) antisense to growth and their application in 2010; PubMed Scopus Google Scholar the for GAS was which is an is by toxic of the that of PNAs into could be by to a to a the are which of acids that are of B of and by and Rev. 2005; PubMed Scopus Google Scholar are and of the to of the and formation of a by the HD AE J P N et the with a formation of J. 97: Full Text Full Text PDF PubMed Scopus Google Scholar The HIV-1 Tat a to which is of by an HD AE a for of the HIV-1 PubMed Scopus Google Scholar of the was to exhibit in cells to E P B A HIV-1 Tat the and in the PubMed Scopus Google Scholar However, and have been in used a HIV-1 Tat for to Growth of GAS in a was with Thereby, an enhanced antimicrobial compared with to Growth inhibition of GAS was application of the was in GAS to a of antisense in combination with low are has been that treatment failure and infections are by the internalization of S. pyogenes into host cells.10Ogawa T Terao Y Okuni H Ninomiya K Sakata H Ikebe K et al.Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitis.Microb Pathog. 2011; 51: 58-68Crossref PubMed Scopus (61) Google Scholar to which into host cells in to and the same low to these therapeutic growth of in was to be inhibited by peptide-coupled P N N et nucleic acids growth of in and in J Full Text Full Text PDF PubMed Scopus Google Scholar of PNAs the for the targeting of the to use in GAS for the of virulence P K S of in of gene PubMed Scopus Google Scholar of gene by antisense to the of virulence and for virulence specific of streptococcal may a therapeutic GAS with virulence could be by the host to a of the of antimicrobial of antimicrobial is an for the of The development of resistance to the can be or by Another is that the of can be in combination with a in antimicrobial synergy can be upon G R Antimicrobial in L M in combination with antibiotics J Full Text Full Text PDF PubMed Scopus Google Scholar therapy may be resistance to a agent Jr, and antimicrobial in Infect Dis. PubMed Scopus Google Scholar in application of antisense PNAs and antibiotics have been in and in S. R N L Antimicrobial synergy between and protein-level 2005; PubMed Scopus Google Scholar The antimicrobial for of the same between peptide-coupled and antibiotics, of the by the antibiotics and that during inhibition of by ribosomal with the are growth inhibition by PNAs as as PNAs upon with antibiotics that antisense PNAs are for combination and PNAs and PNAs with carrier were and by the PNAs used in this are in strains and growth GAS a from a skin was from GAS was cultured in with a to of of GAS were in and to to growth were to in inhibition were in PNAs of in to a of as were In the of novobiocin, or on the growth of GAS of the in the to as indicated were to of was to a of a of was to on the same and of was The were in a which was to the were by on The were a were by At the to was in has been in Growth were in the growth The of antimicrobial was in combination by of the growth In in the of or application of a combination of the Thereby, was as or and synergy as were for as and of was the from as in the by the The was with and with to of The was with of for The was for of and was to the from the by the reactions were by the a was to formation from in the reactions were in The was with an The of gene was used for N A P J A J et of novel growth and in Streptococcus pyogenes PubMed Scopus Google Scholar were on the of S. pyogenes and and was on GAS use in gene was by the of gene and the 2001; PubMed Scopus Google was the between were as with inhibition of the GAS growth by of with of with of levofloxacin with of with of with IntroductionStreptococcus pyogenes (group A streptococci (GAS)) is an exclusively human pathogen, which causes a wide spectrum of infectious diseases ranging from mild superficial infections of the skin and the mucosal membranes to invasive diseases like necrotizing fasciitis (flesh-eating disease) or streptococcal toxic shock syndrome. Typically, superficial infections are associated with spontaneous recovery. However, if mild infections remain untreated, severe invasive infections or autoimmune sequelae can develop as a consequence.1Carapetis JR Steer AC Mulholland EK Weber M The global burden of group A streptococcal diseases.Lancet Infect Dis. 2005; 5: 685-694Abstract Full Text Full Text PDF PubMed Scopus (1903) Google Scholar,2Cunningham MW Pathogenesis of group A streptococcal infections and their sequelae.Adv Exp Med Biol. 2008; 609: 29-42Crossref PubMed Scopus (133) Google Scholar Therefore, antibiotic therapy is strongly indicated upon streptococcal infections. Currently, penicillin is the standard treatment of streptococcal pharyngitis. Reasons are the continuing susceptibility of GAS toward penicillin, its efficiency, safety, and the comparably low costs of penicillin treatment.3Bisno AL Gerber MA Gwaltney Jr, JM Kaplan EL Schwartz RH Infectious Diseases Society of America Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America.Clin Infect Dis. 2002; 35: 113-125Crossref PubMed Scopus (604) Google Scholar,4Dajani A Taubert K Ferrieri P Peter G Shulman S Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association.Pediatrics. 1995; 96 (4 Pt 1): 758-764PubMed Google Scholar,5van Driel ML De Sutter AI Keber N Habraken H Christiaens T Different antibiotic treatments for group A streptococcal pharyngitis.Cochrane Database Syst Rev. 2010; : CD004406PubMed Google Scholar However, penicillin-related treatment failure has been reported repeatedly in cases of streptococcal pharyngitis.6Kuhn SM Preiksaitis J Tyrrel GJ Jadavji T Church D Davies HD Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis.Can J Infect Dis. 2001; 12: 33-39Crossref PubMed Scopus (20) Google Scholar,7Macris MH Hartman N Murray B Klein RF Roberts RB Kaplan EL et al.Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades.Pediatr Infect Dis J. 1998; 17: 377-381Crossref PubMed Scopus (81) Google Scholar Factors that have been discussed to be responsible for this phenomenon include the coexistence of β-lactamase–producing bacteria,8Brook I Gober AE Failure to eradicate streptococci and beta-lactamase producing bacteria.Acta Paediatr. 2008; 97: 193-195Crossref PubMed Scopus (11) Google Scholar biofilm formation by GAS,9Baldassarri L Creti R Recchia S Imperi M Facinelli B Giovanetti E et al.Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation.J Clin Microbiol. 2006; 44: 2721-2727Crossref PubMed Scopus (115) Google Scholar and internalization of GAS into epithelial host cells.10Ogawa T Terao Y Okuni H Ninomiya K Sakata H Ikebe K et al.Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitis.Microb Pathog. 2011; 51: 58-68Crossref PubMed Scopus (61) Google Scholar,11Sela S Neeman R Keller N Barzilai A Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalised by cultured epithelial cells.J Med Microbiol. 2000; 49: 499-502Crossref PubMed Scopus (42) Google Scholar,12Podbielski A Kreikemeyer B Persistence of group A streptococci in eukaryotic cells–a safe place?.Lancet. 2001; 358: 3-4Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar Another problem poses the rising occurrence of macrolide resistance in GAS,13Michos AG Bakoula CG Braoudaki M Koutouzi FI Roma A et resistance in Streptococcus resistance and Infect Dis. Full Text Full Text PDF PubMed Scopus Google J et resistance Streptococcus pyogenes in 2008; PubMed Scopus Google Scholar which the use of to patients with penicillin Shulman treatment failure in streptococcal pharyngitis in acute rheumatic PubMed Scopus Google Scholar the development of novel therapeutic an the therapeutic antisense of antisense interference is the specific on Another is the of resistance toward antisense nucleic acids (PNAs) have been as antimicrobial in the in a of PNAs between and nucleic which are of are in PNAs. However, the nucleic M to nucleic Biol. Google Scholar PNAs a in as as in and their to their in or is to be of PNAs. PNAs to be in human and M et of nucleic acids in human and PubMed Scopus Google is by the in L R in are by the 2000; PubMed Scopus (81) Google Scholar are or that are to eukaryotic cells and can be for the of into B of and by and Rev. 2005; PubMed Scopus Google M M of that with antibiotics PubMed Google Scholar of PNAs into could be by to the M L and of antisense nucleic into 2002; PubMed Scopus Google A antisense nucleic PubMed Scopus Google M K A H growth inhibition by nucleic to the of PubMed Scopus Google P G of gene and growth by antisense nucleic acids in a 51: PubMed Scopus Google Scholar The of essential has been by antisense interference to inhibition of the gene for an factor the gene for the gyrase A the gene for the carrier and the for an P G of gene and growth by antisense nucleic acids in a 51: PubMed Scopus Google H Y H J et inhibition of gene and growth in by of nucleic acids to PubMed Scopus Google A R S M M et in and a Full Text Full Text PDF PubMed Scopus Google Scholar In a has been inhibited by targeting with PNAs specific for the or the M K A H growth inhibition by nucleic to the of PubMed Scopus Google H P A of and growth by nucleic acids to of PubMed Scopus Google a number of PNAs have been in In the antisense was in in and a was to growth M K A H growth inhibition by nucleic to the of PubMed Scopus Google N L of gene and growth antisense nucleic Full Text Full Text PDF PubMed Scopus Google growth of GAS which is a to be responsible for skin and by antisense targeting of the essential gene gene the A of the which is in and is for Growth was PNAs specific for which were to or to PNAs inhibited the growth of GAS more (KFF)3K-coupled a antimicrobial synergy between and
39
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Infectious Diseases Society of America
J. F. Enders · The Journal of Infectious Diseases · 1969 · 3.3K citations